CG ONCOLOGY INC (CGON:NASDAQ)
$73.43 7.09 (10.6874%)
Analysed CG ONCOLOGY INC (CGON:NASDAQ) News Sources
CGON Stock Up 60.8% in Six Months: Here's What You Need to Know
15-04-2026
yahoo.com
As Terns Stock Soars 1,400%, What Does One Fund's $5.2 Million Sale Signal to Investors?
23-03-2026
fool.com
This Biotech Stock Up 135% Just Faced a $44 Million Trim. Here's What Investors Should Know
21-03-2026
fool.com
Is CG Oncology (CGON) Pricing Reflect Its Recent 131% Surge And Cancer Breakthrough Hopes
15-03-2026
yahoo.com
CG Oncology Conference: Credo Posts 75.5% CR in BOND-003, BLA Filing Targeted for 2026
08-03-2026
marketbeat.com
H.C. Wainwright Raises its Price Target on CG Oncology, Inc. (CGON) to $80 and Maintains a Buy Rating
06-03-2026
yahoo.com
Company News for Mar 2, 2026
02-03-2026
yahoo.com
CG Oncology Reports 2025 Year End Financial Results and Provides Business Updates
27-02-2026
yahoo.com
CG Oncology to Present at the TD Cowen 46th Annual Health Care Conference
23-02-2026
yahoo.com
Assessing CG Oncology (CGON) Valuation After Strong Recent Share Price Momentum
23-02-2026
yahoo.com
What is the current price of CG ONCOLOGY INC (CGON:NASDAQ)?
The current price of CG ONCOLOGY INC (CGON:NASDAQ) is $73.43.
CG ONCOLOGY INC (CGON:NASDAQ) absolute price change since previous trading day?
The absolute price change of CG ONCOLOGY INC (CGON:NASDAQ) since the previous trading day is $7.09.
CG ONCOLOGY INC (CGON:NASDAQ) percentage price change since previous trading day?
The percentage price change of CG ONCOLOGY INC (CGON:NASDAQ) since the previous trading day is 10.6874%.
What is the most recent average sentiment score for CG ONCOLOGY INC (CGON:NASDAQ)?
The most recent average sentiment score for CG ONCOLOGY INC (CGON:NASDAQ) is 83 out of 100.
What is the most recent average sentiment for CG ONCOLOGY INC (CGON:NASDAQ)?
The most recent sentiment for CG ONCOLOGY INC (CGON:NASDAQ) is .
SEC-8K** Filing Available For CG ONCOLOGY INC (CGON:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.